• About
    • Advisory Board
    • Network Organisation
    • News archive
    • Achievements
  • Consortium
  • Projects
    • Project 1 (UWr)
    • Project 11 (UWr)
    • Project 2 (UoB)
    • Project 3 (BGU)
    • Project 4 (USC)
    • Project 5 (MUV)
    • Project 6 (MUV)
    • Project 7 (TG)
    • Project 8 (UoW)
    • Project 9 (MUW)
    • Project 10 (TCD)
  • Fellows
  • Training

Cell Lineage Affiliation During Hematopoiesis – Geoffrey Brown

by Anneke_e | Jul 31, 2026 | Publication

This review by Geoffrey Brown (University of Birmingham) revisits the long-standing question of when hematopoietic stem cells (HSCs) become lineage-affiliated during hematopoiesis. The classical model posits that lineage commitment occurs late and proceeds stepwise,...
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma – Pölöske et al.

Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma – Pölöske et al.

by Anneke_e | Jul 31, 2026 | Publication

The transcription factors STAT3, STAT5A, and STAT5B are essential regulators of hematopoiesis and immunity, yet their aberrant activation drives acute myeloid leukemia (AML) and natural killer/T-cell lymphoma (NKCL). Current therapeutic approaches largely target...
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment  – Sternberg et al.

Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment – Sternberg et al.

by Anneke_e | Jul 31, 2026 | Publication

Prostate cancer is the second most commonly diagnosed cancer in men, and IL6ST/STAT3 signaling has been implicated in the progression of several tumor types, yet its specific role in prostate cancer had remained poorly defined. Sternberg et al. addressed this by...
Next Entries »

Recent Posts

  • Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor – Zołek et al.
  • Investigating Tissue Image Quality: Carmen’s Research Visit at Bond University
  • From Tissue Preparation to Image Analysis: Carmen’s Research Visit at La Trobe University
  • Metabolic Interactions of Side-chain Extended and Unsaturated Vitamin D Analogs with Cytochrome P450 Enzymes – Zołek et al.
  • Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth – Fesiuk et al.

Recent Comments

No comments to show.

Developing innovative ligands for Nuclear Receptors to Eradicate Cancer Relapse

About

Consortium

Projects

Fellows

Training

File Hub

Coordinator

Priv.-Doz. Mag. Dr. Martin Schepelmann
(Medical University of Vienna, Austria)
martin.schepelmann@meduniwien.ac.at

Co-Chair

Prof. Andrzej Kutner
(Medical University of Warsaw, Poland)

Project Management

Priv.-Doz. Mag. Dr. Enikö Kallay
(Medical University of Vienna, Austria)
enikoe.kallay@meduniwien.ac.at

Legal Notice Privacy Policy

© 2024

eRaDicate is a Marie Sklodowska Curie Actions Doctoral Network funded by the European Union (Project Number 101119427).